Literature DB >> 27931084

Association of Higher CD4+ CD25high CD127low , FoxP3+ , and IL-2+ T Cell Frequencies Early After Lung Transplantation With Less Chronic Lung Allograft Dysfunction at Two Years.

J Salman1, F Ius1, A-K Knoefel1, W Sommer1, T Siemeni1, C Kuehn1, I Tudorache1, M Avsar1, T Nakagiri1, G Preissler2, R Hatz2, M Greer3, T Welte3, A Haverich1, G Warnecke1.   

Abstract

Regulatory T cells (Treg) can regulate alloantigens and may counteract chronic lung allograft dysfunction (CLAD) in lung transplantation. We analyzed Treg in peripheral blood prospectively and correlated percentages of subpopulations with the incidence of CLAD at 2 years. Among lung-transplanted patients between January 2009 and July 2011, only patients with sufficient Treg measurements were included into the study. Tregs were measured immediately before lung transplantation, at 3 weeks and 3, 6, 12, and 24 months after transplantation and were defined as CD4+ CD25high T cells and further analyzed for CTLA4, CD127, FoxP3, and IL-2 expressions. Between January 2009 and July 2011, 264 patients were transplanted at our institution. Among the 138 (52%) patients included into the study, 31 (22%) developed CLAD within 2 years after transplantation. As soon as 3 weeks after lung transplantation, a statistically significant positive association was detected between Treg frequencies and later absence of CLAD. At the multivariate analysis, increasing frequencies of CD4+ CD25high CD127low , CD4+ CD25high FoxP3+ and CD4+ CD25high IL-2+ T cells at 3 weeks after lung transplantation emerged as protective factors against development of CLAD at 2 years. In conclusion, higher frequencies of specific Treg subpopulations early after lung transplantation are protective against CLAD development.
© 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; clinical research/practice; lung (allograft) function/dysfunction; lung transplantation/pulmonology

Mesh:

Substances:

Year:  2017        PMID: 27931084     DOI: 10.1111/ajt.14148

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  9 in total

1.  An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants.

Authors:  Zhiyi Liu; Fuyi Liao; Davide Scozzi; Yuka Furuya; Kaitlyn N Pugh; Ramsey Hachem; Delphine L Chen; Marlene Cano; Jonathan M Green; Alexander S Krupnick; Daniel Kreisel; Anne Karina T Perl; Howard J Huang; Steven L Brody; Andrew E Gelman
Journal:  JCI Insight       Date:  2019-04-16

2.  A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation.

Authors:  Wiebke Sommer; Jane M O; Kurt B Pruner; Abbas Dehnadi; Kyu Ha Huh; Kortney A Robinson; Isabel Hanekamp; Ivy Rosales; Alison S Bean; Josh Paster; Tetsu Oura; Rex Neal Smith; Robert Colvin; Gilles Benichou; Tatsuo Kawai; Joren C Madsen; James S Allan
Journal:  Transplant Direct       Date:  2021-05-25

3.  Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio.

Authors:  Yin Zongyi; Zou Funian; Li Hao; Wang Xin; Cheng Ying; Zhang Jialin; Liu Yongfeng; Li Baifeng
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

4.  An anti-CD103 antibody-drug conjugate prolongs the survival of pancreatic islet allografts in mice.

Authors:  Da Xue; Pili Liu; Wangming Chen; Chi Zhang; Lei Zhang
Journal:  Cell Death Dis       Date:  2019-09-30       Impact factor: 8.469

5.  α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts.

Authors:  Ann-Kathrin Knöfel; Sabina Janciauskiene; Tomoyuki Nakagiri; Sabine Wrenger; Kokilavani Sivaraman; Fabio Ius; Tobias Goecke; Patrick Zardo; Veronika Grau; Tobias Welte; Axel Haverich
Journal:  Respir Res       Date:  2021-11-17

Review 6.  Novel approaches for long-term lung transplant survival.

Authors:  Cynthia L Miller; Jane M O; James S Allan; Joren C Madsen
Journal:  Front Immunol       Date:  2022-07-27       Impact factor: 8.786

7.  Tumor-infiltrating CD4+ T cells in patients with gastric cancer.

Authors:  Long Yuan; Benling Xu; Peng Yuan; Jinxue Zhou; Peng Qin; Lu Han; Guangyu Chen; Zhenlei Wang; Zengci Run; Peng Zhao; Quanli Gao
Journal:  Cancer Cell Int       Date:  2017-12-02       Impact factor: 5.722

8.  Transient increase of activated regulatory T cells early after kidney transplantation.

Authors:  Young-Seon Mederacke; Florian W Vondran; Sonja Kollrich; Elvira Schulde; Roland Schmitt; Michael P Manns; Jürgen Klempnauer; Reinhard Schwinzer; Fatih Noyan; Elmar Jaeckel
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

Review 9.  Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers.

Authors:  Adrien Tissot; Richard Danger; Johanna Claustre; Antoine Magnan; Sophie Brouard
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.